Saturday, March 30, 2024
Home Tags Pfizer

Tag: Pfizer

Drug candidate offers hope for ER-positive breast cancer patients

An international research collaboration, spearheaded by Pfizer in partnership with Monash University and the Cancer Therapeutics Cooperative Research Centre in Australia, has identified a promising pre-clinical drug candidate with potential anti-tumour activity against Estrogen Receptor (ER) positive breast cancer.

WA gov’t backs Bridgewest with $2M to boost medical manufacturing

Global pharmaceutical company Bridgewest is set to expand its operations in Bentley, transforming the former Pfizer-owned facility into a hub for medical product manufacturing, owing to a $2 million investment from the Western Australian Government.

Bridgewest buys sterile injectable manufacturing plant in Australia

Global private investment firm Bridgewest Group has completed the acquisition of the Perth sterile injectable manufacturing facility from Pfizer. 

Victorian researcher sought for new Pfizer mRNA fellowship program

The Victorian government is backing a fellowship that will support a Victorian researcher to work at Pfizer’s Emerging Science and Innovation Unit RNA Accelerator in the United States in 2023. 

New ‘warm vaccine’ effective against all COVID-19 variants, according to CSIRO study

An international collaboration between scientists from India and Australia is edging closer to delivering a ‘warm’ COVID-19 vaccine suitable for remote and resource-limited locations...

Global pharma giants join forces with Aussie research institutions to develop new cancer treatments

Two global pharmaceutical firms have teamed up with Australian research institutions to develop new treatments and drugs to fight cancer. German pharma giant Boehringer Ingelheim...

Government should invest in Australia’s vaccine manufacturing capability – The Greens

In light of recent AstraZeneca approval for use in Australia, the political party reiterated the need to further diversify jab availability in the country. The...

Pfizer to speed up COVID-19 vaccine manufacture by half as production improves

US-based pharmaceutical company Pfizer will cut down manufacturing time of its COVID-19 vaccines by half – from 110 days to an average of 60...

It’s a no go – Pfizer and Allergan will not merge

Last November, global biopharmaceutical giant Pfizer and Botox maker Allergan announced an all-stock $160 billion merger that would have resulted in the creation of...

$21m upgrade of Pfizer’s hi-tech cancer treatment plant in Adelaide to secure 100 jobs

Global biopharmaceutical company Pfizer has announced the final stage of its $21 million Adelaide facility upgrade that will allow for the commercialisation of the...
Advertisement

Bits Orchestra

Manufacturing Catalyst

Featured Article

Top 3 digitisation outcomes for Aussie manufacturers

As the Australian manufacturing sector faces the challenges and transformations that come with rapid globalisation, the role of digital technology within the industry has never been more critical.Â